The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Emerging data suggest that vancomycin may be less effective against serious methicillin-resistant Staphylococcus aureus (MRSA) infections with minimum inhibitory concentration (MIC) values at the higher end of the susceptibility range. The purpose of this review is to examine the strength of these associations. METHODS: All relevant studies pertaining to treatment outcomes or mortality associated with vancomycin MIC were retrieved from the medical literature from January 1996 through August 2011 and analyzed according to Cochrane guidelines. RESULTS: Of the 270 studies identified, 48 studies were reviewed, with 22 studies included in the final meta-analysis. Vancomycin MIC was significantly associated with mortality for MRSA infection irrespective of the source of infection or MIC methodology (odds ratio [OR], 1.64; 95% confidence interval [CI], 1.14-2.37; P < .01). This mortality association was predominantly driven by bloodstream infections (BSIs; OR, 1.58; 95% CI, 1.06-2.37; P = .03) and isolates with a vancomycin MIC of 2 μg/mL by Etest (OR, 1.72; 95% CI, 1.34-2.21; P < .01). Vancomycin MIC was significantly associated with treatment failure irrespective of source of infection or MIC methodology (OR, 2.69; 95% CI, 1.60-4.51; P < .01). CONCLUSION: High vancomycin MIC was associated with a higher mortality rate in MRSA BSI. Thus, institutions should consider conducting Etest MICs on all MRSA BSI isolates. Although these data highlight concerns about vancomycin, currently, there are no data to support better survival rates with alternative antibiotics. Data are sorely needed to determine whether other agents can remedy these outcomes observed with vancomycin for MRSA infections with elevated vancomycin MIC values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An increasing body of evidence suggests an association between high (but still susceptible on the basis of the Clinical and Laboratory Standards Institute definition) vancomycin MICs in S aureus and worse clinical outcome in both MRSA infections treated with vancomycin 140”
Citations
Cites
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Hidayat, L. K., Hsu, D. I., Quist, R., Shriner, K. A., & Wong-Beringer, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2138 · Cited by 860
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836
Soriano, A., Marco, F., Martinez, J. A., Pisos, E., Almela, M., Dimova, V. P., Alamo, D., Ortega, M., Lopez, J., & Mensa, J. (2008) · Clinical Infectious Diseases · doi:10.1086/524667 · Cited by 767
Moise-Broder, P. A., Forrest, A., Birmingham, M. C., & Schentag, J. J. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443130-00005 · Cited by 757
A Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Lodise, T. P., Graves, J., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B. M., & Stellrecht, K. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-08 · Cited by 553
Self-citationKullar, R., Davis, S. L., Levine, D. P., & Rybak, M. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir124 · Cited by 463 · cited 1×
“Twenty-three studies were excluded for the following reasons: no MIC data were presented against outcomes (11 studies) [16, 24, 27, 29, 30, 31, 33, 46, 51, 56, 57], inappropriate MIC testing methodology was used (3 studies) [13, 35, 44], case reports (2 studies) [11, 38], and nonrelevance (7 studies) [14, 18, 20, 22,…”
MethodSteinkraus, G., White, R., & Friedrich, L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm258 · Cited by 420
Moise-Broder, P. A., Sakoulas, G., Eliopoulos, G. M., Schentag, J. J., Forrest, A., & Moellering, R. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421092 · Cited by 332
Weinstein, R. A., & Fridkin, S. K. (2001) · Clinical Infectious Diseases · doi:10.1086/317542 · Cited by 304
Historical Yearly Usage of Vancomycin
Kirst, H. A., Thompson, D. G., & Nicas, T. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1303 · Cited by 276
Bartlett, J. G. (2004) · Infectious Diseases in Clinical Practice · Cited by 266
Jones, R. N. (2006) · Clinical Infectious Diseases · doi:10.1086/491710 · Cited by 254
Vancomycin: We Can't Get There From Here
Patel, N., Pai, M. P., Rodvold, K. A., Lomaestro, B., Drusano, G. L., & Lodise, T. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir078 · Cited by 247
Self-citationTelavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
Rubinstein, E., Lalani, T., Corey, G. R., Kanafani, Z. A., Nannini, E. C., Rocha, M. G., Rahav, G., Niederman, M. S., Kollef, M. H., Shorr, A. F., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq031 · Cited by 246
Corey, G. R., Wilcox, M., Talbot, G. H., Friedland, H. D., Baculik, T., Witherell, G. W., Critchley, I., Das, A. F., & Thye, D. (2010) · Clinical Infectious Diseases · doi:10.1086/655827 · Cited by 236
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O’Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Gao, W., Christiansen, K. J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir270 · Cited by 228
Moise, P. A., Sakoulas, G., Forrest, A., & Schentag, J. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00939-06 · Cited by 225
Hsu, D. I., Hidayat, L. K., Quist, R., Hindler, J., Karlsson, A., Yusof, A., & Wong-Beringer, A. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.05.007 · Cited by 173
(2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir353 · Cited by 172
Hawkins, C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.17.1861 · Cited by 166
van Hal, S. J., & Paterson, D. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01133-10 · Cited by 165
Self-citationMaor, Y., Hagin, M., Belausov, N., Keller, N., Ben-David, D., & Rahav, G. (2009) · Journal of Infectious Diseases · doi:10.1086/596629 · Cited by 162
Schweizer, M. L., Furuno, J. P., Sakoulas, G., Johnson, J. K., Harris, A. D., Shardell, M. D., McGregor, J. C., Thom, K. A., & Perencevich, E. N. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00918-10 · Cited by 155
Musta, A. C., RIEDERER, K. M., Shemes, S. P., Chase, P., Jose, J., Johnson, L. B., & Khatib, R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02135-08 · Cited by 153
van Hal, S. J., Paterson, D. L., & Gosbell, I. B. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1128-3 · Cited by 139
Self-citationBae, I., Federspiel, J. J., Miró, J. M., Woods, C. W., Park, L., Rybak, M. J., Rude, T. H., Bradley, S., Bukovski, S., de la Maria, C. G., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/606027 · Cited by 122
Horne, K., Howden, B. P., Grabsch, E. A., Graham, M., Ward, P. B., Xie, S., Mayall, B. C., Johnson, P. D. R., & Grayson, M. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01365-08 · Cited by 116
Haque, N. Z., Cahuayme‐Zuniga, L., Peyrani, P., Reyes, K., Lamerato, L. E., Moore, C. L., Patel, S., Allen, M., Peterson, E. L., Wiemken, T. L., et al. (2010) · CHEST Journal · doi:10.1378/chest.09-2453 · Cited by 101
Maclayton, D. O., Suda, K. J., Coval, K. A., York, C. B., & Garey, K. W. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.003 · Cited by 96
Yoon, Y. K., Kim, J., Park, D. W., Sohn, J. W., & Kim, M. J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq050 · Cited by 93
van Hal, S. J., Wehrhahn, M. C., Barbagiannakos, T., Mercer, J. L., Chen, D., Paterson, D. L., & Gosbell, I. B. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02302-10 · Cited by 87
Self-citationChoi, E. Y., Huh, J. W., Lim, C., Koh, Y., Kim, S., Choi, S., Kim, Y. S., Kim, M., & Hong, S. (2011) · Intensive Care Medicine · doi:10.1007/s00134-011-2130-7 · Cited by 84
van Hal, S. J., Jones, M., Gosbell, I. B., & Paterson, D. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021217 · Cited by 84
Self-citationKhatib, R., Jose, J., Musta, A. C., Sharma, M., Fakih, M. G., Johnson, L. B., RIEDERER, K. M., & Shemes, S. P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr169 · Cited by 81
Neoh, H., Hori, S., Komatsu, M., Oguri, T., Takeuchi, F., Cui, L., & Hiramatsu, K. (2007) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-6-13 · Cited by 79
Wang, J., Wang, J., Sheng, W., Chen, Y., & Chang, S. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-159 · Cited by 76
Burnie, J., Matthews, R., Jiman-Fatami, A., Gottardello, P., Hodgetts, S. J., & D’Arcy, S. (2000) · Clinical Infectious Diseases · doi:10.1086/314035 · Cited by 74
Ferry, T., Uçkay, İ., Vaudaux, P. E., François, P., Schrenzel, J., Harbarth, S., Laurent, F. J., Bernard, L., Vandenesch, F., Étienne, J., et al. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0837-y · Cited by 70
Neuner, E. A., Casabar, E., Reichley, R. M., & McKinnon, P. S. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.02.026 · Cited by 66
Khosrovaneh, A., RIEDERER, K. M., Saeed, S., Tabriz, M. S., Shah, A. R., Hanna, M., Sharma, M., Johnson, L. B., Fakih, M. G., & Khatib, R. (2004) · Clinical Infectious Diseases · doi:10.1086/383036 · Cited by 66
Takesue, Y., Nakajima, K., Takahashi, Y., Ichiki, K., Wada, Y., Tsuchida, T., Ishihara, M., Uchino, M., & Ikeuchi, H. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0086-0 · Cited by 61
Holland, T. L., & Fowler, V. G. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir275 · Cited by 60
Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin
Wong, S. S. Y., Ng, T. K., Yam, W.-C., Tsang, D. N., Woo, P. C. Y., Fung, S. K. S., & Yuen, K. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00141-8 · Cited by 57
Price, J. R., Atkinson, S. R., Llewelyn, M., & Paul, J. (2009) · Clinical Infectious Diseases · doi:10.1086/597359 · Cited by 50
Lin, S., Liao, W.-H., Lai, C., Liao, C., Tan, C., Wang, C., Huang, Y., & Hsueh, P. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq188 · Cited by 48
Welsh, K. J., Abbott, A. N., Lewis, E. M., Gardiner, J. M., Kruzel, M. C., Lewis, C. T., Mohr, J., Wanger, A. R., & Armitige, L. Y. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01949-09 · Cited by 44
Lalueza, A., Cháves, F., Juan, R. S., Daskalaki, M., Otero, J. R., & Aguado, J. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/649572 · Cited by 44
Liao, C., Chen, S., Huang, Y., & Hsueh, P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.04.011 · Cited by 39
Shime, N., Kosaka, T., & Fujita, N. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1024-x · Cited by 34
Lubin, A., Snydman, D. R., Ruthazer, R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir118 · Cited by 34
Lutz, L., Machado, A. R. L., Kuplich, N. M., & Barth, A. L. (2003) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702003000300008 · Cited by 31
Lewis, T., Chaudhry, R., Nightingale, P., Lambert, P. A., & Das, I. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.09.013 · Cited by 30
Keel, R. A., Sutherland, C. A., Aslanzadeh, J., Nicolau, D. P., & Kuti, J. L. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.08.006 · Cited by 29
Bland, C. M., Porr, W. H., Davis, K. A., & Mansell, K. B. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181efb5b1 · Cited by 22
Huang, W.-C., Lee, C., & Liu, J.-W. (2010) · Journal of Microbiology Immunology and Infection · doi:10.1016/s1684-1182(10)60073-4 · Cited by 21
Charlesworth, R. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl151 · Cited by 17
Jimenez‐Truque, N., Thomsen, I. P., Saye, E. J., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c52a04 · Cited by 16
Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital
Beeston, C., Gupta, R., Chadwick, P. R., & Young, R. J. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0675-3 · Cited by 16
Porath, A. D., & Brooks, G. D. (2008) · Clinical Infectious Diseases · doi:10.1086/588256 · Cited by 5
Yamaki, J., Lee, M., Shriner, K. A., & Wong‐Beringer, A. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.003 · Cited by 5
Laible, B. R., Hellwig, T. R., & Hedge, D. D. (2011) · PubMed · Cited by 3
Research works printed but not linked: 3
- 2003, MMWR. Morbidity and mortality weekly report, 52, 992
- 2001, MMWR. Morbidity and mortality weekly report, 50, 919
- 2011, S D MED, 64, 91
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,051
The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance
Kowalska-Krochmal, B., & Dudek-Wicher, R. (2021) · Pathogens · doi:10.3390/pathogens10020165 · Cited by 1,039
van Hal, S. J., Paterson, D. L., & Lodise, T. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01568-12 · Cited by 639
Self-citation
Metadata
- Authors
- van Hal, S. J., Lodise, T. P., & Paterson, D. L.
- Affiliations
- Albany College of Pharmacy and Health Sciences (US)
- The University of Queensland (AU)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-02-02
- Volume
- 54
- Issue
- 6
- Pages
- 755-771
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2135788092
- Semantic Scholar
- 98cb0df1b9c8638081a29fa419c35e2491a5e563
- Cited by
- 512
- References
- 69
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 24 · 2021: 27 · 2020: 32 · 2019: 32 · 2018: 32 · 2017: 32 · 2016: 39 · 2015: 59 · 2014: 73 · 2013: 84 · 2012: 29
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Gilead Sciences
- Astellas Pharma
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- vancomycin, minimum inhibitory concentration, methicillin-resistant Staphylococcus aureus, bloodstream infection, mortality, treatment failure, E-test, antibiotic susceptibility, vancomycin resistance
- MeSH terms
- Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Vancomycin, Treatment Failure, Sepsis, Vancomycin Resistance, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.